216 related articles for article (PubMed ID: 21071928)
1. HJV hemochromatosis, iron overload, and hypogonadism in a Brazilian man: treatment with phlebotomy and deferasirox.
Santos PC; Cançado RD; Pereira AC; Chiattone CS; Krieger JE; Guerra-Shinohara EM
Acta Haematol; 2010; 124(4):204-5. PubMed ID: 21071928
[No Abstract] [Full Text] [Related]
2. Non-HFE hemochromatosis: pathophysiological and diagnostic aspects.
Bardou-Jacquet E; Ben Ali Z; Beaumont-Epinette MP; Loreal O; Jouanolle AM; Brissot P
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):143-54. PubMed ID: 24321703
[TBL] [Abstract][Full Text] [Related]
3. Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study.
Cançado R; Melo MR; de Moraes Bastos R; Santos PC; Guerra-Shinohara EM; Chiattone C; Ballas SK
Eur J Haematol; 2015 Dec; 95(6):545-50. PubMed ID: 25684349
[TBL] [Abstract][Full Text] [Related]
4. Iron chelation with deferasirox in two patients with HFE hemochromatosis and chronic anemia.
Nagler M; Gregor M; Wuillemin WA
Acta Haematol; 2011; 126(2):119-21. PubMed ID: 21659727
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of hereditary hemochromatosis.
Salgia RJ; Brown K
Clin Liver Dis; 2015 Feb; 19(1):187-98. PubMed ID: 25454304
[TBL] [Abstract][Full Text] [Related]
6. Current approach to hemochromatosis.
Brissot P; Troadec MB; Bardou-Jacquet E; Le Lan C; Jouanolle AM; Deugnier Y; Loréal O
Blood Rev; 2008 Jul; 22(4):195-210. PubMed ID: 18430498
[TBL] [Abstract][Full Text] [Related]
7. A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.
Phatak P; Brissot P; Wurster M; Adams PC; Bonkovsky HL; Gross J; Malfertheiner P; McLaren GD; Niederau C; Piperno A; Powell LW; Russo MW; Stoelzel U; Stremmel W; Griffel L; Lynch N; Zhang Y; Pietrangelo A
Hepatology; 2010 Nov; 52(5):1671-779. PubMed ID: 20814896
[TBL] [Abstract][Full Text] [Related]
8. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
Inati A; Kahale M; Sbeiti N; Cappellini MD; Taher AT; Koussa S; Nasr TA; Musallam KM; Abbas HA; Porter JB
Pediatr Blood Cancer; 2017 Jan; 64(1):188-196. PubMed ID: 27576370
[TBL] [Abstract][Full Text] [Related]
9. Deferasirox reduces iron overload in a murine model of juvenile hemochromatosis.
Nick H; Allegrini PR; Fozard L; Junker U; Rojkjaer L; Salie R; Niederkofler V; O'Reilly T
Exp Biol Med (Maywood); 2009 May; 234(5):492-503. PubMed ID: 19234060
[TBL] [Abstract][Full Text] [Related]
10. [Hereditary iron overload].
Brissot P; Bardou-Jacquet E; Latournerie M; Ropert-Bouchet M; Island ML; Loréal O; Jouanolle AM
Pathol Biol (Paris); 2010 Oct; 58(5):316-23. PubMed ID: 19942367
[TBL] [Abstract][Full Text] [Related]
11. Iron overload disorders: treatment options for patients refractory to or intolerant of phlebotomy.
Bring P; Partovi N; Ford JA; Yoshida EM
Pharmacotherapy; 2008 Mar; 28(3):331-42. PubMed ID: 18294113
[TBL] [Abstract][Full Text] [Related]
12. Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R.
Lee PL; Barton JC
Acta Haematol; 2006; 115(1-2):102-5. PubMed ID: 16424658
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in hemochromatosis: a 2015 update : a summary of proceedings of the 2014 conference held under the auspices of Hemochromatosis Australia.
Ekanayake D; Roddick C; Powell LW
Hepatol Int; 2015 Apr; 9(2):174-82. PubMed ID: 25788196
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of genetic haemochromatosis].
Milman NT
Ugeskr Laeger; 2013 Apr; 175(16):1109-12. PubMed ID: 23651749
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary hemochromatosis].
Niederau C
Internist (Berl); 2003 Feb; 44(2):191-205; quiz 206-7. PubMed ID: 12674739
[TBL] [Abstract][Full Text] [Related]
16. Iron overload: molecular clues to its cause.
Kühn LC
Trends Biochem Sci; 1999 May; 24(5):164-6. PubMed ID: 10322426
[No Abstract] [Full Text] [Related]
17. Hereditary hemochromatosis--a new look at an old disease.
Pietrangelo A
N Engl J Med; 2004 Jun; 350(23):2383-97. PubMed ID: 15175440
[No Abstract] [Full Text] [Related]
18. Revisiting hereditary hemochromatosis: current concepts and progress.
Yen AW; Fancher TL; Bowlus CL
Am J Med; 2006 May; 119(5):391-9. PubMed ID: 16651049
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of iron overload syndrome].
Polunina TE; Maev IV
Eksp Klin Gastroenterol; 2010; (5):61-8. PubMed ID: 20731136
[TBL] [Abstract][Full Text] [Related]
20. Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management.
Nelson JE; Kowdley KV
Curr Gastroenterol Rep; 2005 Feb; 7(1):71-80. PubMed ID: 15701302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
